Pillstats
Rx only · Suspension · Oral

Carospir

Spironolactone

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03DA01
RxCUI (US)9997
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.01$2.03$3.04$4.06Oct 2025May 2026Jun 2026
$3.452
Latest avg · Jun 17, 2026
-2%
Since Oct 22, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3506991.0K1.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
511
Rx · 2026 Q1
74K
Units dispensed
-58%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
CMP Pharma, Inc.unknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.